Gadolinium-based contrast agents used in MRI angiography and patent information analysisGUO Wen-juan, HUANG Lu, SHI Lu-wen1153-1159
Analysis of influencing factors for innovation paradox of original drugsWU He-song, HUANG Lu1160-1163
Andexanet alfa, the first approved specific antagonist of FXa inhibitorsXIAO Sheng-wei, LI Wei-wei, DU Xue-ting1164-1168
Pharmacological effects and clinical evaluation of benralizumab in the treatment of severe asthmaLI Lang, FENG Yu-fei, WANG Zhi-hong1169-1171
Effect of cimetidine on the expression of SOD2 and GPX1 in low-dose accumulatively irradiated beagle dogsLIU Yu-ming, HE Ying, ZHAO Yi-ning, SHEN Xian-rong, WANG Qing-rong, LI Ke-xian, LUO Qun, CHEN Wei, HOU Deng-yong, JIANG Ding-wen1172-1177
Optimization on extraction process of Jinghong granules based on orthogonal design and multi-index weight analysisLIU Gui-hua, WANG Yun-fei, YU Ning, XING Jian-guo, HE Cheng-hui1178-1184
Research status of targeting homologous recombinant protein Rad51 in the mechanism of breast cancerXU Xiu-li, BU Ri-gu-de, MA Jin-zhu1185-1191
Beyond lipid-lowering: progress in researches for Xuezhikang in cardiovascular protection and its mechanismsFENG Shu-jun, TANG Xin-ying, WANG Ying, KUANG Ze-min1192-1196
Progress in researches for normegestrol acetate: a novel progestinCAO Can, XIE Shu-wu, ZHU Yan1197-1202
Pharmacokinetics and bioequivalence of metronidazole tablet in healthy volunteersFENG Shi-yin, CAI Lin-rui, CHENG Zhuo, SU Xu, ZOU Qin, GUO Wei-yi, WANG Jing, YU Qin1203-1207